Patent intelligence · AU
AU 2002328956
17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
Patent details — AU 2002328956
- Jurisdiction
- AU
- Status
- granted
- Grant date
- Aug 16, 2007
- Expiration
- Aug 11, 2027
- Applicant
- CASSIOPEA S P A [IT]
- CPC classes
- A61K 31/ 573 A I, A61K/31573, A61K/3170, A61K/4706
Quick answer
AU 2002328956 (17alfa, 21-dihydroxypregnene esters as antiandrogenic agents) is held by CASSIOPEA S P A [IT]. Status: granted. Granted Aug 16, 2007. Expires Aug 11, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- CASSIOPEA S P A [IT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 573 A I, A61K/31573, A61K/3170, A61K/4706, A61K/4710, A61K/4712
More from CASSIOPEA S P A [IT]
Related pharmaceutical patents in our USPTO index.
-
WO 2026087531
FORMULATIONS DE CLASCOTÉRONE ET LEURS MÉTHODES D'UTILISATION
granted -
WO 2026057588
POLYTHÉRAPIE À BASE DE CLASCOTÉRONE ET DE MINOXIDIL POUR LE TRAITEMENT DE LA PERTE DES CHEVEUX
granted -
WO 2025172818
POLYTHÉRAPIE À BASE DE PYRILUTAMIDE
granted -
WO 2025125508
COMBINAISONS DE CORTEXOLONE-17ΑLPHA-PROPIONATE POUR LE TRAITEMENT DE L'ACNÉ
granted -
AR 132316
TRATAMIENTO COMBINADO CON CLASCOTERONA Y MINOXIDIL
granted -
WO 2025068281
CORTÉXOLONE-17α-PROPIONATE POUR LE TRAITEMENT D'ÉRUPTIONS ACNÉIFORMES
granted -
EP 4529925
CORTEXOLON-17-ALPHA-PROPIONAT ZUR BEHANDLUNG VON AKNEIFORMEN ERUPTEN
granted -
US 2018169113
HIGH CONCENTRATION FORMULATION
granted
Frequently asked questions
What is US patent 2002328956?
AU 2002328956 (17alfa, 21-dihydroxypregnene esters as antiandrogenic agents) is held by CASSIOPEA S P A [IT]. Status: granted. Granted Aug 16, 2007. Expires Aug 11, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns AU 2002328956?
CASSIOPEA S P A [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 12 pharmaceutical patents for this assignee.
When does AU 2002328956 expire?
Our index shows an expiration date of Aug 11, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.